ONCOEXPRESS
DEAD

Serial Number

87074832

Owner

Crown Bioscience Inc.

Attorney

Yi Zhang

First Use Date

Feb 9, 2017

Filing Date

Jun 17, 2016

Add to watchlist:

No watchlists yet
View on USPTO

ONCOEXPRESS Trademark

Serial Number: 87074832 • Registration: 5649690

ONCOEXPRESS is a trademark filed by Crown Bioscience Inc. on June 17, 2016. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Crown Bioscience Inc. (29 trademarks)

Santa Clara, CA 95054

Entity Type: 03

Trademark Details

Filing Date

June 17, 2016

Registration Date

January 8, 2019

First Use Anywhere

February 9, 2017

First Use in Commerce

February 9, 2017

Published for Opposition

April 11, 2017

Cancellation Date

July 18, 2025

Goods & Services

Downloadable software in the nature of a mobile application for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; computer application software for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models., namely, software for searching for genomic, pharmaceutical, histological, clinical and other data; computer software for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models that may be downloaded from a global computer network; downloadable mobile applications for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; downloadable software in the nature of a mobile application for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models

Providing a website featuring information about health and wellness, namely, genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing a website featuring information about health, namely, hepatitis awareness, diagnosis and information about screening and treatment; providing a website featuring information about health, wellness and nutrition; providing a website featuring information concerning alternative health and healing; providing a website featuring information in the field of the diagnosis and treatment of Cancer and tumors; providing a website via a global computer network featuring information in the fields of health, cancer, cancer recovery and survival; providing an internet website for medical professionals and medical patients featuring medical information from remote locations via devices that feed information to the website that is processed, exchanged and accessed in real-time by users; providing an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed in formation to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions

Providing a website featuring a search engine for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing a website featuring non-downloadable software for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing a website featuring on-line non-downloadable software that enables users to search for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; Providing a website featuring technology that enables users to search for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; Providing a website for the electronic storage of genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing a website that gives computer users the ability to search for genomic, pharmaceutical, histological, clinical and other data of Patient derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing a members-only website featuring technology which provides members with the ability to search for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing a secured-access, members only website featuring technology that gives members the ability to search for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing a web site featuring temporary use of non-downloadable software for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; Providing a website featuring on-line non-downloadable software that enables users to search for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; Providing a website featuring resources, namely, a website featuring primarily non-downloadable software for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models and also featuring nondownloadable publications in the nature of genomic, pharmaceutical, histological and clinical journals in the field of medical diagnosis and treatment; Providing a website featuring resources, namely, non-downloadable software for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing an interactive website featuring technology that allows users to search for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing on-line non-downloadable software for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing temporary use of on-line non-downloadable software and applications for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing a website featuring resources, namely, a website featuring primarily non-downloadable software for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models and also featuring non-downloadable publications in the nature of genomic, pharmaceutical, histological and clinical journals in the field of medical diagnosis and treatment

Filing History

CANCELLED SEC. 8 (6-YR)
Jul 18, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 8, 2024 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 28, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 28, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 28, 2021 REAP
REGISTERED-PRINCIPAL REGISTER
Jan 8, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 5, 2018 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 4, 2018 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 20, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2018 CRFA
ASSIGNED TO LIE
Nov 16, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 6, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 28, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jun 28, 2018 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jun 28, 2018 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jun 25, 2018 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 25, 2018 AITU
USE AMENDMENT FILED
Jun 5, 2018 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 5, 2018 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 7, 2017 EXRA
SOU EXTENSION 1 GRANTED
Dec 5, 2017 EX1G
SOU EXTENSION 1 FILED
Dec 5, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 5, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 6, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 11, 2017 NPUB
PUBLISHED FOR OPPOSITION
Apr 11, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 22, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 6, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 1, 2017 CNSA
DATA MODIFICATION COMPLETED
Feb 24, 2017 DMCC
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2017 CRFA
ASSIGNED TO LIE
Feb 20, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 11, 2016 GNRN
NON-FINAL ACTION E-MAILED
Aug 11, 2016 GNRT
NON-FINAL ACTION WRITTEN
Aug 11, 2016 CNRT
ASSIGNED TO EXAMINER
Aug 4, 2016 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Jun 23, 2016 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 22, 2016 NWOS
NEW APPLICATION ENTERED
Jun 21, 2016 NWAP